Weiss Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.82M Buy
3,070
+2,702
+734% +$2.74M 0.05% 234
2025
Q4
$395K Buy
+368
New +$352K 0.01% 497
2025
Q1
Sell
-26,316
Closed -$20.3M 524
2024
Q4
$20.3M Buy
+26,316
New +$21.8M 0.38% 60
2024
Q3
Sell
-298
Closed -$270K 644
2024
Q2
$270K Sell
298
-130
-30% -$104K 0.01% 216
2024
Q1
$333K Buy
+428
New +$305K 0.01% 236
2021
Q3
Sell
-29,672
Closed -$6.81M 573
2021
Q2
$6.81M Buy
+29,672
New +$5.96M 0.17% 175
2020
Q1
Sell
-1,905
Closed -$250K 276
2019
Q4
$250K Sell
1,905
-520
-21% -$60.3K 0.02% 188
2019
Q3
$271K Buy
+2,425
New +$270K 0.02% 177

Other funds holding LLY

Weiss Asset Management's LLY Position: Q1 2026 in Review

Weiss Asset Management increased its Eli Lilly (LLY) stake by 734% in Q1 2026, buying an estimated $2.74M and bringing the position to 3,070 shares worth $2.82M. The position accounts for 0.05% of the portfolio, ranked #234.

Weiss Asset Management first reported a position in LLY in Q3 2019 and has held it in 8 quarters since. The position peaked at $20.3M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Weiss Asset Management held 3,070 shares of Eli Lilly worth $2.82M as of Q1 2026.
  • Weiss Asset Management bought 2,702 Eli Lilly shares in Q1 2026, an estimated $2.74M.
  • Eli Lilly made up 0.05% of Weiss Asset Management's portfolio in Q1 2026, its #234 holding.
  • Weiss Asset Management first reported a position in Eli Lilly in Q3 2019 and has held it in 8 quarters since.
  • Weiss Asset Management's Eli Lilly position peaked at $20.3M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Weiss Asset Management's 13F filing for Q1 2026, filed 15 May 2026.